Private markets · Pre-IPO

Own a stake in tomorrow's public companies, before the bell rings.

Black Hawk Investment Partners brings a close circle of investors together to secure allocations in exceptional late-stage private companies. We pool our capital, negotiate as one, and hold each position with care until it reaches the public market.

Join our investor group
Pre-IPOLate-stage focus
$1M+Capital deployed
PrivateBy invitation

Current portfolio

Where our partners' capital is invested

Black Hawk partners have backed some of the most sought-after private companies in the world. Below are the names we have taken allocations in, and the capital committed to each position we hold today.

Loading the portfolio…

Our approach

How a Black Hawk allocation comes together

Every investment follows the same disciplined path, from first conversation to final distribution.

i.

Source

We identify pre-IPO companies with the potential for significant growth after they go public, and work only with selected, verified market partners.

ii.

Analyze

Each opportunity goes through our 21-point due diligence review. We then negotiate the share price based on our combined investment volume and current market conditions.

iii.

Pool

Partners commit capital to that specific company. Shares are usually bought on the secondary market, and directly from the company when that is available.

iv.

Realize

In most cases shares are sold about six months after the IPO, subject to lock-up periods and market conditions, and proceeds are returned to partners.

Due diligence

A 21-point review before any partner capital moves

Before Black Hawk commits a dollar, the opportunity is tested against the parameters below, in the manner of a private-equity and venture investment committee. We don't just ask whether a company is attractive. We ask whether the deal is attractive at the price we can actually buy today.

01

Entry price & price per share

Offered price per share, the price in the most recent funding round and in earlier rounds, the premium or discount against that latest round, whether the security is common or preferred, how its rights differ from institutional holders', the fully diluted share count and the implied valuation.

02

Valuation analysis

Current and prior round valuations, growth between rounds, revenue, ARR and forward revenue, price-to-sales and EV/revenue multiples, sector multiples, comparable public and private companies, and how much future growth is already priced in.

03

Effective entry valuation

The effective entry premium, effective price per share and effective entry valuation we actually pay, measured against the headline figure, and the valuation the company must reach for partners to break even.

04

True cost of entry

Acquisition and offering costs, SPV and administrative expenses, ongoing charges and carried interest, totalled over three, five and seven years, so the headline company return is never confused with a partner's net return.

05

Minimum investment & capital efficiency

The minimum commitment, compared against competing private-market opportunities, and whether a $10K, $25K, $50K or $100K allocation produces materially different economics, direct ownership or better liquidity.

06

Business & prospects

The problem solved and why customers need it, total and serviceable market, industry trends, competitive advantage, intellectual property, technology differentiation, switching costs, network effects, barriers to entry, scalability, and recurring against one-off revenue.

07

Customers, orders & future revenue

Signed contracts, purchase orders, backlog, letters of intent, reservations, strategic agreements, pilots, government contracts, commercial deployments and partnerships — with confirmed revenue kept strictly apart from backlog, LOIs, pipeline and speculative opportunities.

08

Revenue & growth

Historical revenue by year, year-on-year growth and valuation-to-revenue, then bear, base and bull cases for the next three to five years with every assumption stated.

09

Competitor analysis

Direct, indirect, incumbent and emerging competitors compared on technology, cost, performance, scalability, customer traction, capital raised, revenue, valuation, partnerships, manufacturing capability and market share.

10

Investor quality

Venture firms, strategic corporate investors, sovereign wealth funds, private equity and institutional holders, founder ownership, and whether existing investors followed on. A respected backer is never treated as proof the price is right.

11

Funding & dilution

The full round history, total capital raised, likely future capital requirements, the probability of further dilution before an IPO, capital intensity, cash burn and runway.

12

IPO timeline & exit options

Management statements, investment-bank involvement, public-company hires, SEC filings, auditor and governance changes, secondary transactions and tender offers. Exit windows of one to two, three to five, or five-plus years, alongside acquisition, strategic sale, tender offer, secondary sale, merger or staying private. Rumours are never presented as plans.

13

IPO valuation scenarios

Bear, base and bull IPO valuations, each measured against our entry, and what they would be worth on a $10K, $25K, $50K or $100K commitment.

14

Post-IPO upside

Valuation at listing and three and five years afterwards, built on stated revenue-growth and multiple assumptions rather than presented as certainties.

15

Liquidity & lock-up risk

Expected holding period, restrictions on secondary transfers, right of first refusal, company approval requirements, SPV restrictions, the 180-day IPO lock-up and how realistically shares can be sold beforehand.

16

Cap table & security risk

Preferred against common stock, liquidation preferences, senior securities, convertible notes, SAFEs, warrants, employee options, RSUs, the fully diluted count and future dilution — and whether preferred holders would receive materially different economics.

17

Key risks

Execution, technology, competition, customer concentration, manufacturing, supply chain, capital requirements, regulation, valuation compression, dilution, founder dependence, profitability, IPO delay, market cycle and secondary-market liquidity. Company-specific, never generic disclaimers.

18

Catalysts

New funding, a major customer, a large contract, product launches, manufacturing and revenue milestones, profitability, strategic partnerships, government contracts, international expansion, an IPO filing or acquisition interest — separated into near-term and long-term.

19

Return scenarios

Outcomes at 0.5×, 1×, 2×, 3×, 5× and 10×, with net proceeds, net multiple on invested capital and annualised return at three, five and seven years, plus the valuation required for break-even and for 1.5×, 2×, 3× and 5× net returns.

20

Comparative opportunity analysis

Three to five comparable private companies side by side on entry valuation, growth, revenue traction, technology moat, backlog, investor quality, minimum investment, capital requirements, IPO readiness, dilution and liquidity.

21

Final investment summary

A single dashboard carrying every figure above, followed by the investment thesis, the counter-thesis, what must go right, what could go wrong, and ten to fifteen questions put to the seller before any capital moves.

Evidence standard

Every important number carries a date and one of four labels. Nothing unavailable is estimated as fact, and IPO rumors are never presented as plans.

VerifiedCompany-reportedEstimatedRumored / unconfirmed

Sources include SEC filings, company and funding announcements, PitchBook and Crunchbase, Reuters, Bloomberg, the Financial Times, CNBC, government contract databases and competitors' 10-K and 10-Q filings.

Focused

We concentrate on late-stage private companies preparing for a public listing, where the step from private to public markets can create value for early holders.

Verified

We transact only through selected and verified market partners, for credibility and transparency in every allocation.

Candid about risk

All investments carry risk, including the loss of capital. Future market performance can't be guaranteed, and a company may never go public.

Exit strategy

Built to be held through the IPO

This is a long-term strategy, and we encourage partners to stay invested through the IPO process. Shares are generally sold around six months after listing, once lock-up periods end and market conditions allow.

If you need to exit before the IPO, Black Hawk may arrange an internal auction of your shares among other partners. An early exit depends on a buyer being available and on the terms that apply at the time.

Join the circle

Hear about the next allocation first

New opportunities, deadlines and updates are shared in our private investor group on WhatsApp.

Join on WhatsApp chat.whatsapp.com/KS2TAIuWaQx6IgZAXuUEIb